Matches in Wikidata for { <http://www.wikidata.org/entity/Q67132955> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q67132955 description "clinical trial" @default.
- Q67132955 description "ensayu clínicu" @default.
- Q67132955 description "klinisch onderzoek" @default.
- Q67132955 description "клінічне випробування" @default.
- Q67132955 name "Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Dose-Adjusted-Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (DA-TEDDI-R) in Primary CNS Lymphoma" @default.
- Q67132955 name "Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Dose-Adjusted-Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (DA-TEDDI-R) in Primary CNS Lymphoma" @default.
- Q67132955 type Item @default.
- Q67132955 label "Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Dose-Adjusted-Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (DA-TEDDI-R) in Primary CNS Lymphoma" @default.
- Q67132955 label "Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Dose-Adjusted-Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (DA-TEDDI-R) in Primary CNS Lymphoma" @default.
- Q67132955 prefLabel "Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Dose-Adjusted-Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (DA-TEDDI-R) in Primary CNS Lymphoma" @default.
- Q67132955 prefLabel "Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Dose-Adjusted-Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (DA-TEDDI-R) in Primary CNS Lymphoma" @default.
- Q67132955 P1050 Q67132955-B37F0887-96B3-4CCA-8BB0-B8DBB75D8B78 @default.
- Q67132955 P1132 Q67132955-BBC6F581-754D-4E4A-B65D-AA31B6000812 @default.
- Q67132955 P1476 Q67132955-E38677DE-C69B-4066-BB68-8B00CF5986C4 @default.
- Q67132955 P17 Q67132955-3E74F9D9-8475-453E-8467-66887C8ABC0B @default.
- Q67132955 P2899 Q67132955-581BF494-B261-42E6-B7A9-DB7D9984313A @default.
- Q67132955 P3098 Q67132955-90E623FC-4596-4739-9A82-E24E855175AF @default.
- Q67132955 P31 Q67132955-D2AE9E81-F82C-4F7E-8786-7B26BC249143 @default.
- Q67132955 P4135 Q67132955-AB3FB753-81FC-493E-A9B4-37C485EFC43F @default.
- Q67132955 P4844 Q67132955-019B9080-D7A1-4653-A36D-5C47C539C979 @default.
- Q67132955 P4844 Q67132955-18CDF1D7-600E-4EA4-85B0-9A25AAE2DB65 @default.
- Q67132955 P4844 Q67132955-2BB7657E-5769-452B-AF39-B1770C21D149 @default.
- Q67132955 P4844 Q67132955-2E1C92B0-4CDB-41FD-BECF-2DA06EDA115E @default.
- Q67132955 P4844 Q67132955-5C0FB674-5F2F-4460-8DBE-F7365DDE59D6 @default.
- Q67132955 P4844 Q67132955-80611097-9C1E-4862-8550-C3FCCA94D168 @default.
- Q67132955 P580 Q67132955-4BED05FC-DE2B-4B9D-9D0E-2CC89DB09E18 @default.
- Q67132955 P582 Q67132955-95DAC0E2-94DD-45BF-87DB-01898F534465 @default.
- Q67132955 P6099 Q67132955-273C68A0-F06F-47DE-A84D-496C4241690D @default.
- Q67132955 P8363 Q67132955-876B0B1C-E3B5-482A-9608-01099FE6EF10 @default.
- Q67132955 P1050 Q208414 @default.
- Q67132955 P1132 "+52" @default.
- Q67132955 P1476 "Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Dose-Adjusted-Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (DA-TEDDI-R) in Primary CNS Lymphoma" @default.
- Q67132955 P17 Q30 @default.
- Q67132955 P2899 "+18" @default.
- Q67132955 P3098 "NCT02203526" @default.
- Q67132955 P31 Q30612 @default.
- Q67132955 P4135 "+100" @default.
- Q67132955 P4844 Q180983 @default.
- Q67132955 P4844 Q27260984 @default.
- Q67132955 P4844 Q29004943 @default.
- Q67132955 P4844 Q408524 @default.
- Q67132955 P4844 Q412323 @default.
- Q67132955 P4844 Q6079042 @default.
- Q67132955 P580 "2014-08-14T00:00:00Z" @default.
- Q67132955 P582 "2022-06-15T00:00:00Z" @default.
- Q67132955 P6099 Q5452194 @default.
- Q67132955 P8363 Q78089383 @default.